Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
for Colonic Neoplasms
Drug: Dostarlimab
49 locations incl. Tucson
Sponsor: GlaxoSmithKline
Sex: All·Age: 18+
Code: NCT05855200·Phase 3·Recruiting